358 related articles for article (PubMed ID: 25064148)
1. Innovations in diagnosis and post-therapeutic monitoring of Chagas disease: Simultaneous flow cytometric detection of IgG1 antibodies anti-live amastigote, anti-live trypomastigote, and anti-fixed epimastigote forms of Trypanosoma cruzi.
Alessio GD; Côrtes DF; Machado de Assis GF; Júnior PA; Ferro EA; Antonelli LR; Teixeira-Carvalho A; Martins-Filho OA; de Lana M
J Immunol Methods; 2014 Nov; 413():32-44. PubMed ID: 25064148
[TBL] [Abstract][Full Text] [Related]
2. Non-conventional flow cytometry approaches to detect anti-Trypanosoma cruzi immunoglobulin G in the clinical laboratory.
Vitelli-Avelar DM; Sathler-Avelar R; Wendling AP; Rocha RD; Teixeira-Carvalho A; Martins NE; Dias JC; Rassi A; Luquetti AO; Elói-Santos SM; Martins-Filho OA
J Immunol Methods; 2007 Jan; 318(1-2):102-12. PubMed ID: 17161421
[TBL] [Abstract][Full Text] [Related]
3. Double-blind study to evaluate flow cytometry analysis of anti-live trypomastigote antibodies for monitoring treatment efficacy in cases of human Chagas' disease.
Martins-Filho OA; Eloi-Santos SM; Teixeira Carvalho A; Oliveira RC; Rassi A; Luquetti AO; Rassi GG; Brener Z
Clin Diagn Lab Immunol; 2002 Sep; 9(5):1107-13. PubMed ID: 12204967
[TBL] [Abstract][Full Text] [Related]
4. Performance of TcI/TcVI/TcII Chagas-Flow ATE-IgG2a for universal and genotype-specific serodiagnosis of Trypanosoma cruzi infection.
Alessio GD; de Araújo FF; Côrtes DF; Sales Júnior PA; Lima DC; Gomes MS; do Amaral LR; Xavier MA; Teixeira-Carvalho A; Martins-Filho OA; de Lana M
PLoS Negl Trop Dis; 2017 Mar; 11(3):e0005444. PubMed ID: 28333926
[TBL] [Abstract][Full Text] [Related]
5. Applicability of an optimized non-conventional flow cytometry method to detect anti-Trypanosoma cruzi immunoglobulin G for the serological diagnosis and cure assessment following chemotherapeutic treatment of Chagas disease.
Matos CS; Coelho-Dos-Reis JG; Rassi A; Luquetti AO; Dias JC; Eloi-Santos SM; Gomes IT; Vitelli-Avelar DM; Wendling AP; Rocha RD; Teixeira-Carvalho A; Peruhype-Magalhães V; Andrade MC; Martins-Filho OA
J Immunol Methods; 2011 Jun; 369(1-2):22-32. PubMed ID: 21477591
[TBL] [Abstract][Full Text] [Related]
6. The use of IgG antibodies in conventional and non-conventional immunodiagnostic tests for early prognosis after treatment of Chagas disease.
Wendling AP; Vitelli-Avelar DM; Sathler-Avelar R; Geiger SM; Teixeira-Carvalho A; Gontijo ED; Elói-Santos SM; Martins-Filho OA
J Immunol Methods; 2011 Jul; 370(1-2):24-34. PubMed ID: 21620855
[TBL] [Abstract][Full Text] [Related]
7. Accomplishing the genotype-specific serodiagnosis of single and dual Trypanosoma cruzi infections by flow cytometry Chagas-Flow ATE-IgG2a.
Alessio GD; de Araújo FF; Sales Júnior PA; Gomes MS; Amaral LRD; Pascoal Xavier MA; Teixeira-Carvalho A; de Lana M; Martins-Filho OA
PLoS Negl Trop Dis; 2018 Feb; 12(2):e0006140. PubMed ID: 29462135
[TBL] [Abstract][Full Text] [Related]
8. Anti-Trypanosoma cruzi immunoglobulin G1 can be a useful tool for diagnosis and prognosis of human Chagas' disease.
Cordeiro FD; Martins-Filho OA; Da Costa Rocha MO; Adad SJ; Corrêa-Oliveira R; Romanha AJ
Clin Diagn Lab Immunol; 2001 Jan; 8(1):112-8. PubMed ID: 11139203
[TBL] [Abstract][Full Text] [Related]
9. Flow cytometry, a new approach to detect anti-live trypomastigote antibodies and monitor the efficacy of specific treatment in human Chagas' disease.
Martins-Filho OA; Pereira ME; Carvalho JF; Cançado JR; Brener Z
Clin Diagn Lab Immunol; 1995 Sep; 2(5):569-73. PubMed ID: 8548536
[TBL] [Abstract][Full Text] [Related]
10. Troponin T autoantibodies correlate with chronic cardiomyopathy in human Chagas disease.
Nunes DF; Guedes PM; Andrade Cde M; Câmara AC; Chiari E; Galvão LM
Trop Med Int Health; 2013 Oct; 18(10):1180-92. PubMed ID: 23906320
[TBL] [Abstract][Full Text] [Related]
11. High resolution of Trypanosoma cruzi amastigote antigen in serodiagnosis of different clinical forms of Chagas' disease.
Matsumoto TK; Hoshino-Shimizu S; Nakamura PM; Andrade HF; Umezawa ES
J Clin Microbiol; 1993 Jun; 31(6):1486-92. PubMed ID: 8314991
[TBL] [Abstract][Full Text] [Related]
12. [Cysteine-dependent protease in Trypanosoma cruzi useful for the diagnosis of Chagas disease].
Alberti Amador E; Fachado Carvajales A; Montalvo AM; Izquierdo Pérez LA; Fonte Galindo L
Rev Cubana Med Trop; 1998; 50(1):75-81. PubMed ID: 9842273
[TBL] [Abstract][Full Text] [Related]
13. Chagas'disease: IgA, IgM and IgG antibodies to T. cruzi amastigote, trypomastigote and epimastigote antigens in acute and in different chronic forms of the disease.
Primavera KS; Umezawa ES; Peres BA; Camargo ME; Hoshino-Shimizu S
Rev Inst Med Trop Sao Paulo; 1990; 32(3):172-80. PubMed ID: 2135370
[TBL] [Abstract][Full Text] [Related]
14. Field evaluation of four novel enzyme immunoassays for Chagas' disease in Venezuela blood banks: comparison of assays using fixed-epimastigotes, fixed-trypomastigotes or trypomastigote excreted-secreted antigens from two Trypanosoma cruzi strains.
Berrizbeitia M; Ndao M; Bubis J; Gottschalk M; Aché A; Lacouture S; Medina M; Ward BJ
Transfus Med; 2006 Dec; 16(6):419-31. PubMed ID: 17163873
[TBL] [Abstract][Full Text] [Related]
15. Use of Trypanosoma cruzi purified glycoprotein (GP57/51) or trypomastigote-shed antigens to assess cure for human Chagas' disease.
Gazzinelli RT; Galvao LM; Krautz G; Lima PC; Cancado JR; Scharfstein J; Krettli AU
Am J Trop Med Hyg; 1993 Nov; 49(5):625-35. PubMed ID: 8250103
[TBL] [Abstract][Full Text] [Related]
16. May the epimastigote form of Trypanosoma cruzi be infective?
De Souza W; Barrias ES
Acta Trop; 2020 Dec; 212():105688. PubMed ID: 32888934
[TBL] [Abstract][Full Text] [Related]
17. [Preliminary evaluation of the commercial kit Chagas ( Trypanosoma cruzi ) IgG-ELISA ® in Colombian individuals].
Llano M; Pavía P; Flórez AC; Cuéllar A; González JM; Puerta C
Biomedica; 2014; 34(2):228-36. PubMed ID: 24967928
[TBL] [Abstract][Full Text] [Related]
18. Trypanosoma cruzi: Immunological predictors of benznidazole efficacy during experimental infection.
Fernández MC; González Cappa SM; Solana ME
Exp Parasitol; 2010 Feb; 124(2):172-80. PubMed ID: 19747482
[TBL] [Abstract][Full Text] [Related]
19. Detection of anti-leishmania (Leishmania) chagasi immunoglobulin G by flow cytometry for cure assessment following chemotherapeutic treatment of American visceral leishmaniasis.
Lemos EM; Gomes IT; Carvalho SF; Rocha RD; Pissinate JF; Martins-Filho OA; Dietze R
Clin Vaccine Immunol; 2007 May; 14(5):569-76. PubMed ID: 17360851
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of serological tests to identify Trypanosoma cruzi infection in humans and determine cross-reactivity with Trypanosoma rangeli and Leishmania spp.
Caballero ZC; Sousa OE; Marques WP; Saez-Alquezar A; Umezawa ES
Clin Vaccine Immunol; 2007 Aug; 14(8):1045-9. PubMed ID: 17522327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
